Kembali ke Pencarian
2026 Artikel Jurnal Scopus/WOS Terdampak Faktor (SSCI,SCIE,SCI) B.2 - (Q2) WOS IF 0,5-0,9 Selesai

Early On-Treatment Dynamics of HIF-1α after the 10th Radiotherapy Fraction: Paired Pre–Post IHC Study across Breast Cancer Molecular

International Journal of Veterinary Science Meta Zulyati Oktora

Penulis / Author

1
Meta Zulyati Oktora (Universitas Baiturrahmah) Utama

Detail Publikasi

International Journal of Veterinary Science

Unique Scientific Publishers

15

4

1108-1114

2305-4360

Abstrak

Tumor hypoxia, regulated by hypoxia-inducible factor-1α (HIF-1α), is a central mediator of radioresistance in breast cancer. Although baseline HIF-1α has been studied as a prognostic marker, early on-treatment dynamics of HIF-1α during fractionated radiotherapy across molecular subtypes remain poorly characterized. This study aims to evaluate changes in tumor HIF-1α expression between baseline (pre-RT) and after the 10th radiotherapy fraction (post-RT fraction 10), and to assess whether changes differ across IHC-defined molecular subtypes. This prospective observational paired pre–post study included invasive breast cancer patients with available paired FFPE tissue (pre-RT and post-fraction-10). HIF-1α expression was quantified as the percentage of positive tumor cells on IHC. Molecular subtypes (Luminal A, Luminal B, HER2-enriched, triple-negative) were assigned using IHC surrogates with a Ki-67 cut-off of 20 %. Changes were expressed as ΔHIF (post–pre) and %ΔHIF. Between-subtype comparisons were assessed using one-way ANOVA (or non-parametric equivalents as appropriate). Forty-four patients were included (mean age 50.07 ± 9.77 years; 97.7 % female). HIF-1α decreased after fraction 10 across subtypes. Mean ΔHIF (95 % CI) was −6.91 (−11.73 to −2.09) for Luminal A, −5.66 (−7.54 to −3.78) for Luminal B, −4.57 (−8.35 to −0.79) for HER2-enriched, and −2.86 (−7.26 to 1.54) for triple-negative. Between-subtype differences were not statistically significant for ΔHIF (P = 0.400) or %ΔHIF (P = 0.348). As a preliminary, exploratory finding, tumor HIF-1α expression showed an early decrease by the 10th radiotherapy fraction across all IHC-defined molecular subtypes. The magnitude of change did not significantly differ by subtype, suggesting early HIF-1α modulation may represent a shared on-treatment microenvironmental response rather than a subtype-specific phenomenon. These exploratory findings require validation in larger, prospective, multi-center cohorts, but support further evaluation of HIF-1α as an on-treatment biomarker of early radiotherapy response.

Dana Insentif

B.2 - (Q2) WOS IF 0,5-0,9

Rp 20.000.000

Dana Disetujui

Rp 20.000.000

Dicairkan

04 Nov 2026

Alur Proses

Klaim Diajukan

27 Jul 2026

Verifikasi Fakultas

27 Jul 2026

Verifikasi Rektorat

12 Oct 2026

Verifikasi Sekretaris

06 Aug 2026

Disetujui Ka LPPM

06 Aug 2026

Dana Dicairkan

04 Nov 2026
Status Saat Ini Selesai

Informasi Dosen

MZ

Meta Zulyati Oktora

NIDN: 1002108502

Lektor

Fakultas Fakultas Kedokteran
Prodi Profesi Dokter
... online